Skip to main content
SpringerLink
Log in

Effect of transmembrane pressure on Factor VIII yield in ATF perfusion culture for the production of recombinant human Factor VIII co-expressed with von Willebrand factor

  • Original Article
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

In this study, we evaluated three cell retention devices, an alternating tangential flow (ATF) system, a spin-filter, and a Centritech Lab III centrifuge, for the production of recombinant human Factor VIII co-expressed with von Willebrand factor. From the results, it was found that the FVIII activity in bioreactor was significantly higher in the ATF perfusion culture than two other perfusion cultures. Moreover, the FVIII activity yield was unexpectedly low in the ATF perfusion culture. We have, therefore, studied the reasons for this low FVIII activity yield. It was revealed that the inactivation and the surface adsorption of FVIII onto the harvest bag were not the main reasons for the low yield in the ATF perfusion culture. The FVIII activity yield was not increased by the use of a hollow fiber filter with 0.5 μm pore size instead of 0.2 μm pore size. Additionally, the retention of FVIII molecules by the hollow fiber filter was a dominant factor in the low FVIII activity yield in the ATF perfusion culture. We demonstrated that FVIII yield was significantly improved by controlling transmembrane pressure (TMP) across the hollow fiber filter membrane. Taken together, these results suggest that TMP control could be an efficient method for the enhancement of FVIII yield in an ATF perfusion culture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Berntorp E (1997) Second generation, B-domain deleted recombinant factor VIII. Thromb Haemost 78:256–260

    CAS  Google Scholar 

  • Boedeker BG (2001) Production processes of licensed recombinant factor VIII preparations. Semin Thromb Hemost 27:385–394

    Article  CAS  Google Scholar 

  • Casademunt E, Martinelle K, Jernberg M, Winge S, Tiemeyer M, Biesert L, Knaub S, Walter O, Schroder C (2012) The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics. Eur J Haematol 89:165–176

    Article  CAS  Google Scholar 

  • Clincke MF, Molleryd C, Zhang Y, Lindskog E, Walsh K, Chotteau V (2013) Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor. Part I. Effect of the cell density on the process. Biotechnol Prog 29:754–767

    Article  CAS  Google Scholar 

  • Crowley J, Wubben M, Martin JMC (2012) Process for cell culturing by continuous perfusion and alternating tangential flow. US Patent 8206981 B1

  • Himmelfarb P, Thayer PS, Martin HE (1969) Spin filter culture: the propagation of mammalian cells in suspension. Science 164:555–557

    Article  CAS  Google Scholar 

  • Hoyer LW, Shainoff JR (1980) Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers. Blood 55:1056–1059

    CAS  Google Scholar 

  • Ishaque A, Thrift J, Murphy JE, Konstantinov K (2007) Over-expression of Hsp70 in BHK-21 cells engineered to produce recombinant factor VIII promotes resistance to apoptosis and enhances secretion. Biotechnol Bioeng 97:144–155

    Article  CAS  Google Scholar 

  • Jiang R, Monroe T, McRogers R, Larson PJ (2002) Manufacturing challenges in the commercial production of recombinant coagulation factor VIII. Haemophilia 8(Suppl 2):1–5

    Article  Google Scholar 

  • Johnson M, Lanthier S, Massie B, Lefebvre G, Kamen AA (1996) Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Prog 12:855–864

    Article  CAS  Google Scholar 

  • Kaufman RJ, Pipe SW (1999) Regulation of factor VIII expression and activity by von Willebrand factor. Thromb Haemost 82:201–208

    CAS  Google Scholar 

  • Kaufman RJ, Wasley LC, Dorner AJ (1988) Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 263:6352–6362

    CAS  Google Scholar 

  • Kaufman RJ, Wasley LC, Davies MV, Wise RJ, Israel DI, Dorner AJ (1989) Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell Biol 9:1233–1242

    Article  CAS  Google Scholar 

  • Kelley B, Jankowski M, Booth J (2010) An improved manufacturing process for Xyntha/ReFacto AF. Haemophilia 16:717–725

    Article  CAS  Google Scholar 

  • Kim BJ, Oh DJ, Chang HN (2008) Limited use of Centritech Lab II centrifuge in perfusion culture of rCHO cells for the production of recombinant antibody. Biotechnol Prog 24:166–174

    Article  CAS  Google Scholar 

  • McLeod A, Walker I, Zheng S, Hayward C (2000) Loss of factor VIII activity during storage in PVC containers due to adsorption. Haemophilia 6:89–92

    Article  CAS  Google Scholar 

  • Mei B, Chen Y, Chen J, Pan CQ, Murphy JE (2006) Expression of human coagulation factor VIII in a human hybrid cell line, HKB11. Mol Biotechnol 34:165–178

    Article  CAS  Google Scholar 

  • Mercille S, Johnson M, Lemieux R, Massie B (1994) Filtration-based perfusion of hybridoma cultures in protein-free medium: reduction of membrane fouling by medium supplementation with DNase I. Biotechnol Bioeng 43:833–846

    Article  CAS  Google Scholar 

  • Mufarrege EF, Antuña S, Etcheverrigaray M, Kratje R, Prieto C (2014) Development of lentiviral vectors for transient and stable protein overexpression in mammalian cells. A new strategy for recombinant human FVIII (rhFVIII) production. Protein Expr Purif 95:50–56

    Article  Google Scholar 

  • Selvaraj SR, Scheller AN, Miao HZ, Kaufman RJ, Pipe SW (2012) Bioengineering of coagulation factor VIII for efficient expression through elimination of a dispensable disulfide loop. J Thromb Haemost 10:107–115

    Article  CAS  Google Scholar 

  • Seyfried BK, Friedbacher G, Rottensteiner H, Schwarz HP, Ehrlich H, Allmaier G, Turecek PL (2010) Comparison of plasma-derived and recombinant von Willebrand factor by atomic force microscopy. Thromb Haemost 104:523–530

    Article  CAS  Google Scholar 

  • Shankaran H, Alexandridis P, Neelamegham S (2003) Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood 101:2637–2645

    Article  CAS  Google Scholar 

  • Shevitz J (2003) Fluid filtration system. US 6544424 B1

  • Tokashiki M, Arai T, Hamamoto K, Ishimaru K (1990) High density culture of hybridoma cells using a perfusion culture vessel with an external centrifuge. Cytotechnology 3:239–244

    Article  CAS  Google Scholar 

  • Vlot AJ, Koppelman SJ, van den Berg MH, Bouma BN, Sixma JJ (1995) The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 85:3150–3157

    CAS  Google Scholar 

  • Ward NJ, Buckley SM, Waddington SN, VandenDriessche T, Chuah MK, Nathwani AC, McIntosh J, Tuddenham EG, Kinnon C, Thrasher AJ (2011) Codon optimization of human factor VIII cDNAs leads to high-level expression. Blood 117:798–807

    Article  CAS  Google Scholar 

  • Weiss HJ, Sussman II, Hoyer LW (1977) Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand’s disease. J Clin Invest 60:390–404

    Article  CAS  Google Scholar 

  • Wise RJ, Dorner A, Krane M, Pittman D, Kaufman R (1991) The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem 266:21948–21955

    CAS  Google Scholar 

  • Yabannavar VM, Singh V, Connelly NV (1992) Mammalian cell retention in a spinfilter perfusion bioreactor. Biotechnol Bioeng 40:925–933

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Institute, Dong-A Socio-Holdings Co., Ltd., Yong-in, 449-900, Republic of Korea

    Seung-Chul Kim, Sora An, Hyun-Ki Kim, Beom-Soo Park & Kyu-Heum Na

  2. Interdisciplinary Program for Bioengineering, Seoul National University, Seoul, 151-742, Republic of Korea

    Seung-Chul Kim & Byung-Gee Kim

  3. School of Chemical and Biological Engineering, College of Engineering, Institute of Bioengineering, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul, 151-744, Republic of Korea

    Byung-Gee Kim

Authors
  1. Seung-Chul Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sora An
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyun-Ki Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Beom-Soo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyu-Heum Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Byung-Gee Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Byung-Gee Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, SC., An, S., Kim, HK. et al. Effect of transmembrane pressure on Factor VIII yield in ATF perfusion culture for the production of recombinant human Factor VIII co-expressed with von Willebrand factor. Cytotechnology 68, 1687–1696 (2016). https://doi.org/10.1007/s10616-015-9918-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-015-9918-1

Keywords

Search

Navigation